香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 對因本公告全部或任何部份內容而產生或因倚賴該等內容而引致之任 何 損 失 承 擔 任 何 責 任。 Qingdao Gon Technology Co., Ltd. 青島國恩科技股份有限公司 （於 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 司） （股 份 代 號：2768） 海外監管公告 本 公 告 乃 由 青 島 國 恩 科 技 股 份 有 限 公 司（「本公司」）根 據 香 港 聯 合 交 易 所 有限公司證券上市規則第13.10B條 作 出。 茲 載 列 本 公 司 於 深 圳 證 券 交 易 所 網 站 發 佈 之 以 下 公 告，僅 供 參 閱： 1. 第五屆董事會第十八次會議決議公告 2. 2025年度董事會工作報告 3. 2025年 度 獨 立 董 事 述 職 報 告（孫 建 強） 4. 2025年 度 獨 立 董 事 述 職 報 告（項 婷） 7. 2025年年度報告 8. 2025年年度報告 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不對因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的 任 何 損 失 承 擔 任 何 責 任。 Qingdao Gon Technology Co., Ltd. 本 公 告 乃 由 青 島 國 恩 科 技 股 份 有 限 公 司（「本公司」）董 事（「董 事」）會（「董 事 會」）根 據 香 港 聯 合 交 易 所 有 限 公 司 證券上市規則（「上市規則」）第13.51(4) 條 而 刊 發。 採用中國企業會計準則 根 據 香港聯合交易所有限公司（「香 港 聯交所」）於2010年12月 刊 發 的《有 關 接受在香港上市的內地註冊成立公司採用內地的會計及審計準則以及 聘 用 內 地 會 計 師 事 務 所 的 諮 詢 總 結》，於 中 國 內 地 註 冊 成 立 的 香 港 上 市 發 行 人 已 獲 准 採 用 中 國 企 業 會 計 準 則（「中國企業會計準則」）編 製 其 財 務 報 表，而 獲 中 華 人 民 共 和 國 ...

EF001 免責聲明 EF001 發行人所發行上市權證/可轉換債券的相關信息 發行人所發行上市權證/可轉換債券 不適用 其他信息 其他信息 不適用 發行人董事 王愛國先生，李宗好先生，李慧穎女士，韓博先生，王亞平先生，孫建強先生，項婷女士 第 2 頁 共 2 頁 v 1.1.1 | 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因 | | | --- | --- | | 公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 | | | 股票發行人現金股息公告 | | | 發行人名稱 | 青島國恩科技股份有限公司 | | 股份代號 | 02768 | | 多櫃檯股份代號及貨幣 | 不適用 | | 相關股份代號及名稱 | 不適用 | | 公告標題 | 截至2025年12月31日止年度的末期股息 | | 公告日期 | 2026年3月30日 | | 公告狀態 | 新公告 | | 股息信息 | | | 股息類型 | 末期 | | 股息性質 | 普通股息 | | 財政年末 | 2025年12月31日 | | 宣派股息的報 ...

Financial Performance - Total revenue for the year ended December 31, 2025, was approximately RMB 21,251.2 million, an increase of about 10.8% compared to RMB 19,187.5 million for the year ended December 31, 2024[4] - Gross profit for the year ended December 31, 2025, was approximately RMB 2,210.4 million, representing an increase of about 38.8% from RMB 1,592.2 million in 2024, with a gross margin of 10.4% compared to 8.3% in 2024[4] - Net profit for the year ended December 31, 2025, was approximately RMB 836.8 million, a 16.1% increase from RMB 720.6 million in 2024, with a net profit margin of 3.9% compared to 3.8% in 2024[4] - Basic earnings per share for the year ended December 31, 2025, was RMB 3.22, up from RMB 2.56 in 2024[6] - The company reported a total comprehensive income of RMB 821.7 million for the year ended December 31, 2025, compared to RMB 719.9 million in 2024[5] - The profit before tax for the fiscal year 2025 was RMB 961,032, compared to RMB 797,075 in 2024, reflecting an increase of approximately 20.6%[21] - Net profit increased by approximately 16.1% from about RMB 720.6 million in fiscal year 2024 to approximately RMB 836.8 million in fiscal year 2025[58] Revenue Breakdown - Revenue from green petrochemical new materials was RMB 5,289,697 thousand in 2025, up from RMB 3,869,138 thousand in 2024, indicating a significant increase of about 36.8%[14] - Revenue from organic polymer modified materials was RMB 10,357,221 thousand in 2025, slightly up from RMB 10,324,910 thousand in 2024, indicating a marginal growth of about 0.3%[14] - Revenue from organic polymer composite materials increased to RMB 3,917,302 thousand in 2025 from RMB 3,175,422 thousand in 2024, marking a growth of approximately 23.3%[14] - The revenue from the Chemical New Materials segment was RMB 20,506,084 for 2025, up from RMB 18,334,935 in 2024, indicating a growth of about 11.9%[17] - The health segment's revenue decreased by approximately 12.6% to about RMB 745.5 million in fiscal year 2025, primarily due to market volatility affecting product prices and sales volume[49] Assets and Liabilities - Non-current assets totaled RMB 7,529.3 million as of December 31, 2025, compared to RMB 7,337.8 million in 2024[7] - Current assets amounted to RMB 12,258.5 million as of December 31, 2025, an increase from RMB 11,013.6 million in 2024[7] - The net asset value of the company as of December 31, 2025, was RMB 7,700,338 thousand, compared to RMB 7,032,329 thousand in 2024, reflecting a growth of approximately 9.5%[8] - Current liabilities totaled RMB 8,400,688 thousand in 2025, an increase from RMB 7,455,575 thousand in 2024, which is an increase of about 12.7%[8] - Non-current liabilities totaled RMB 3,686,826 thousand in 2025, a decrease from RMB 3,863,544 thousand in 2024, reflecting a reduction of approximately 4.6%[8] - The total liabilities of the company, including trade payables and notes payable, amounted to RMB 5,027,001 thousand in 2025, up from RMB 4,755,502 thousand in 2024, marking an increase of about 5.7%[25] Expenses and Costs - Research and development expenses for the year ended December 31, 2025, were RMB 685.5 million, compared to RMB 591.3 million in 2024[5] - The total employee costs for 2025 were RMB 678,546, an increase from RMB 548,983 in 2024, reflecting a growth of approximately 23.5%[22] - Selling and marketing expenses increased by approximately 6.8% to about RMB 144.2 million in fiscal year 2025, driven by the recruitment of additional sales personnel[53] - Other income and gains decreased by approximately 70.0% to about RMB 101.4 million in fiscal year 2025, primarily due to reduced VAT deductions and impairment losses[52] Dividends and Shareholder Information - The board has proposed a final dividend of RMB 0.5 per share for the year ended December 31, 2025, subject to approval at the upcoming annual general meeting[4] - The board has proposed a final dividend of RMB 0.5 per share, amounting to approximately RMB 147.5 million, subject to approval at the upcoming annual general meeting[87] - The company plans to issue a total of 127,200,000 A-shares and 14,400,000 H-shares as part of the capital reserve conversion plan for 2025, increasing the total number of shares to 442,850,000[89] Corporate Governance - The company is committed to maintaining high standards of corporate governance and has adhered to all applicable codes since the listing date[83] - The audit committee has reviewed the consolidated annual performance for the year ending December 31, 2025, and confirmed compliance with applicable accounting standards and regulations[95] - The company’s governance structure includes an audit committee to oversee financial reporting and compliance[100] Future Plans and Market Outlook - The company plans to further expand its product range in the health sector to cover various sub-sectors including medical, beauty, health, and food[33] - The company plans to establish a regional headquarters in Hong Kong to integrate R&D, branding, and global marketing functions, leveraging local high-performance polystyrene production and deep-water port capabilities[38] - The overseas organic polymer modification market is projected to grow from approximately ¥0.96 trillion in 2024 to ¥1.64 trillion by 2029, with a compound annual growth rate (CAGR) of about 14.3% from 2025 to 2029[37] - The domestic chemical new materials market is expected to reach ¥1.12 trillion in 2024 and exceed ¥1.60 trillion by 2029, with a CAGR of approximately 7.4% from 2024 to 2029[39] - The health sector is a key component of the company's strategy, with the Chinese health market projected to grow at a CAGR of about 8.0%, reaching ¥14.8 trillion by 2029[41]

（於 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 司） 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不就因本公告全部或任何部份內容而產生或因倚賴該等內容而引致之 任 何 損 失 承 擔 任 何 責 任。 Qingdao Gon Technology Co., Ltd. 青島國恩科技股份有限公司 青 島 國 恩 科 技 股 份 有 限 公 司（「本公司」）董 事 會（「董事會」）謹 此 宣 佈，本 公 司 將 於 二 零 二 六 年 三 月 三 十 日（星 期 一）舉 行 董 事 會 會 議，藉 以（其 中 包 括） 考慮及批准本公司及其附屬公司截至二零二五年十二月三十一日止年 度 的 業 績 及 其 刊 發，並 考 慮 建 議 派 發 末 期 股 息（如 有）。 承董事會命 青島國恩科技股份有限公司 董事長兼執行董事 （股 份 代 號：2768） 董事會會議召開日期 王愛國先生 香 港，2026年3月18日 於 本 公 告 日 期，本 公 司 董 事 會 成 ...

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年2月28日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 青島國恩科技股份有限公司 呈交日期: 2026年3月5日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02768 | 說明 | H股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 30,000,000 | RMB | | 1 | RMB | | 30,000,000 | | 增加 / 減少 (-) | | | 0 | | | | RMB | | 0 | | 本月底結存 | | | 30,000,000 | RMB | | 1 | RMB | | 30,000,000 | | 2. 股份分類 ...

(A joint stock company incorporated in the People's Republic of China with limited liability) （於中華人民共和國註冊成立的股份有限公司） (Stock Code 股份代號: 2768) 26 February 2026 Dear non-registered shareholder(s), QINGDAO GON TECHNOLOGY CO., LTD. 青島國恩科技股份有限公司 以電子方式發布公司通訊之安排 根據自 2023 年 12 月 31 日起生效的擴大無紙化上市機制及以電子方式發布公司通訊規定下香港聯合交易所有限公司證券上市規則（「上市規則」）第 2.07A 條，青島國恩科技股份有限公司（「公司」）謹此通知 閣下，公司已採用以電子方式發布公司通訊（「公司通訊」）之安排，該公司通訊是指 公司為向其任何證券持有人提供資訊或提醒其採取行動而發布或將要發布的任何文件，包括但不限於(a) 董事會報告、年度帳目以及審計報告副本以及 （如適用）財務摘要報告； (b) 中期報告及其中期報告摘要（如適用）； (c) 會議通知 ...

QINGDAO GON TECHNOLOGY CO., LTD. 青島國恩科技股份有限公司 (A joint stock company incorporated in the People's Republic of China with limited liability) （於中華人民共和國註冊成立的股份有限公司） (Stock Code 股份代號: 2768) 26 February 2026 Dear registered shareholder(s), Pursuant to Rule 2.07A of the Rules Governing The Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules") under the expansion of paperless listing regime and electronic dissemination of corporate communications that came into effect on 31 Decembe ...

Core Insights - The report highlights significant changes in the Hong Kong Stock Connect holdings, with notable increases and decreases in ownership percentages for various companies [1][2][3] Group 1: Increased Holdings - Xixiang Group (02473) saw the largest increase in holdings, up by 4.32%, bringing its total to 45.14% [2] - Zhaoyi Innovation (03986) and Yingfu Fund (02800) also experienced increases of 2.65% and 2.54%, respectively, with holdings of 6.65% and 3.52% [2] - Over the last five trading days, Xixiang Group (02473) had a remarkable increase of 16.84%, while Junda Co. (02865) and Zhaoyi Innovation (03986) increased by 11.07% and 5.84% [1][3] Group 2: Decreased Holdings - Zhaoyan Pharmaceutical (06127) experienced the largest decrease in holdings, down by 0.73%, now at 62.32% [2] - Fortior Technology (Shenzhen) Co., Ltd. (01304) and CICC (03908) saw decreases of 0.57% and 0.38%, with holdings of 22.26% and 32.29% respectively [2] - In the last five trading days, Guoen Technology (02768) had the largest decrease of 4.14%, followed by Sinopec Engineering (02386) with a decrease of 3.60% [3][4] Group 3: Long-term Trends - Over the past 20 days, Xixiang Group (02473) had a substantial increase of 42.15% in holdings, while Junda Co. (02865) increased by 14.80% [4] - Conversely, Kanglong Chemical (03759) and Tianqi Lithium (09696) saw significant decreases of 6.70% and 6.56% in their holdings [4]

Group 1 - The article highlights the top three companies with the highest AH premium rates: Northeast Electric (00042) at 785.25%, Beijing Jingcheng Machinery Electric (00187) at 291.45%, and Sinopec Oilfield Service (01033) at 284.04% [1] - The bottom three companies with the lowest AH premium rates are CATL (03750) at -16.62%, WuXi AppTec (02359) at -6.17%, and China Merchants Bank (03968) at -3.27% [1] - The article provides a detailed ranking of the top ten and bottom ten AH stocks based on their premium rates and deviation values, indicating significant disparities in market valuations between A-shares and H-shares [1][2] Group 2 - The top three companies with the highest deviation values are Beijing Jingcheng Machinery Electric (00187) at 23.16%, Dongjiang Environmental Protection (00895) at 18.78%, and Zhongzhou Securities (01375) at 16.54% [1] - Conversely, the companies with the lowest deviation values include Morning Paper (01812) at -52.60%, Junda Co., Ltd. (02865) at -34.18%, and Changfei Optical Fiber Cable (06869) at -34.18% [1][2] - The article emphasizes that the deviation value represents the difference between the current premium rate and the average premium rate over the past 30 days, providing insights into market trends [2]